In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nancy Dvorin

Managing Editor

Connecticut, US
Nancy Dvorin joined the IN VIVO staff in 1999 to report on emerging life science companies. She has been managing editor of the publication since 2009, and responsible for producing IN VIVO’s insightful coverage of the biopharma, medtech and diagnostics industries. Before joining IN VIVO, Nancy managed library and information services for a number of multinational corporations. She’s delighted that her passion for delivering useful, actionable intelligence to clients has translated well from the information service to the information provider arena.
Set Alert for Articles By Nancy Dvorin

Latest From Nancy Dvorin

In Vivo's Deals Of The Month, October 2017

In Vivo's editors pick October's most significant deals, including bold moves from Vir Biotechnology and the birth of a major generics player. (Free article.)

Deals BioPharmaceutical

In Vivo's Deals Of The Month, September 2017

In Vivo's editors pick September's most significant deals, including lucrative partnerships for Halozyme and the pursuit of Dimension Therapeutics. (Free article.)

BioPharmaceutical Deals

In Vivo's Deals Of The Century: A Timeline

When it comes to deal-making, In Vivo's editors have always been quick to single out transactions that we feel will spark trends or otherwise have a major impact on the life sciences industry. Below, an expandable timeline of the deals we chose as bellwethers for pharma and medtech in each year of this still-young century and what we said about them at the time. (Free article.)

BioPharmaceutical Medical Device

In Vivo's Deals Of The Month, August 2017

In Vivo's editors pick August's most significant deals, including Gilead's acquisition of Kite and AstraZeneca's Parkinson's deals. (Free article.)

Deals Market Intelligence

Infographic: Human Capital In Biopharma

A sampling of data from In Vivo and the EBD Academy's comprehensive survey, Future-Proofing Human Capital In Global Life Sciences.

BioPharmaceutical Leadership

In Vivo's Deals Of The Month, July 2017

In Vivo's editors pick July's most significant deals, including AZ and Merck's oncology deal, and late-stage funding for Silk Road Medical. (Free article.)

BioPharmaceutical Deals
See All